Screener
Moderna MRNA Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Moderna’s reported figures.
The source filing: Moderna’s 8-K, filed July 31, 2026. Open the filing →
- Filed
- Jul 31, 2026, 7:03 AM EDT
- Accession
- 0001682852-26-000147
FAQ
- What is Moderna's free cash flow?
- Moderna (MRNA) reported free cash flow of -$563M in Q2 2026.
- How has Moderna's free cash flow changed year-over-year?
- Moderna's free cash flow increased by 38.9% year-over-year, from -$922M to -$563M.
- What is the long-term trend for Moderna's free cash flow?
- Over 2 years (2021 to 2024), Moderna's free cash flow has grown at a -42.8% compound annual growth rate (CAGR), from $13.34B to -$4.36B.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Moderna's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude